KARLI BRUBAKER: Open Payments
NPI 1558873166 · FLINT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 33 payments from 15 companies in 2025. Trend: 2023 $865 · 2024 $652 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $228 |
| Otsuka America Pharmaceutical, Inc. | 4 | $103 |
| Novo Nordisk Inc | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $73 |
| Amgen Inc. | 3 | $59 |
| ABBVIE INC. | 2 | $37 |
| Abbott Laboratories | 1 | $24 |
| SANOFI-AVENTIS U.S. LLC | 1 | $23 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Xeris Pharmaceuticals, Inc. | 1 | $21 |
Products named: FARXIGA, REXULTI, TRELEGY ELLIPTA, Rybelsus, BREZTRI, EVENITY, Ozempic, FREESTYLE LIBRE 3.
Industry payments across MI — which companies pay providers there.
